As everyone knows, the Great Recession or 2008 and 2009 has taken its toll on most industries and the biotools supply industry is no exception. However, there is real evidence that the light at the end of the tunnel is getting a bit brighter. Stimulus dollars from the American Recovery and Reinvestment Act of 2009 have finally started to…read more >
There has certainly been a lot of content generated recently about the virtues of the “new marketing” and the focus on niche segments, consumer to consumer communication, and permission vs. interruption approaches. Is it a real revolution or a fad? The question we prefer is: what’s the difference? So let’s see what your average dictionary says about these terms.
At Percepta, our first point of contact is at times an overworked product manager blurting, “I need to field a survey on…insert topic here…and I need the data back by…insert excessively tight deadline here.” Our approach is generally to convince them to come down off of the ledge, take a deep breath, and provide us with the answers to…read more >
Life Science Research Tools Companies Stand to Benefit from Sharp Increase in NIH Grant Funding, New Market Research Report Finds
According to a new market research from Percepta, US life scientists anticipate $7.4 billion in new NIH grant funds by 2010
Carlsbad, CA – August 12, 2009 – Percepta Associates announced today the release of a new complimentary market research report Life Science Research Funding Optimism In The United States: A Researcher’s Perspective. The report details the anticipated impact of…read more >
As a marketing consultancy that serves the research biotools industry, Percepta’s business is more or less directly linked to the market dynamics of life science research in general. These market dynamics can be – well … dynamic. For example, as noted in earlier posts, research funding is the engine that drives the research biotools industry and to a large…read more >
In the past few years Percepta has had several clients come to us saying in essence “We know we have the best products – just help us find the customers”. This is illustrative of the all too common view that since we have the best widget for whatever bench application all we need to do is show it to…read more >
Last October our little consultancy looked around and noticed things had begun to slow down a bit. New business wasn’t banging at the door and we had to face an unpleasant truth – we were not as immune to the economic downturn as we had hoped.
Percepta is a San Diego area marketing consultancy serving biological research tools suppliers. You…read more >
Significant Potential For Share Gain in Fluctuating Nucleic Acid Amplification Research Product Market
The New Nucleic Acid Amplification Series 2 Life Science Dashboard™ from Percepta Associates projects significant potential for switching primary amplification product suppliers
Carlsbad, Calif. – July 14, 2009 – Today Percepta Associates announced the launch of the 2009 Nucleic Acid Amplification Series 2 Life Science Dashboard™ market research report
which draws comparisons to key market indicator data reported in Percepta’s 2007…
Change in End User Habits Revealed in Over Half Billion Dollar Nucleic Acid Purification Research Market
New Nucleic Acid Purification Series 2 Life Science Dashboard™ from Percepta Associates projects significant growth in microRNA and total RNA purification segments
Carlsbad, Calif. – June 23, 2009 – Today Percepta Associates launched its 2009 Nucleic Acid Purification Series 2 Life Science Dashboard™ market research report which draws comparisons to key market indicator data reported in Percepta’s 2007 Nucleic Acid…read more >
The novel program mines customer databases for customer trends and new sales opportunities.
Carlsbad, California – June 16, 2009 – Percepta Associates announced today that they have implemented a new program to profile life scientists for research supply companies. The Profile™ Program is designed to give suppliers an up-to-date customer profile sheet summarizing their existing customer’s practices and views regarding…read more >